Meloxicam long-acting injection (Nanjing Qingpu Biological Tech)

Product Name :
Meloxicam long-acting injection (Nanjing Qingpu Biological Tech)

Search keywords :
Meloxicam

drugId :
null

Target Vo:
Cyclooxygenase-2

Target Vo Short Name :
COX-2

Moa_Name:
Cyclooxygenase-2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Nanjing Qingpu Biological Tech Co Ltd

Active Company_Name :
Nanjing Qingpu Biological Tech Co Ltd

Active Indication_Name:
Pain

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
NDA/BLA

China Highest Status:
NDA/BLA

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Trastuzumab duocarmazine Epigenetics
Rituximab (anti-CD20) Immunology/Inflammation
Synaptophysin Antibody (YA043): Synaptophysin Antibody (YA043) is a non-conjugated and Rabbit origined monoclonal antibody about 38 kDa, targeting to Synaptophysin. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts